CAMP Competitors & Alternatives
Compare CAMP4 THERAPEUTICS CORPORATION with similar stocks in the same industry
Biotechnology
CAMP
Main Stock$3.95
+2.33%
Tradestie Score
42
Market Cap
$59.48M
Revenue Growth
138.9%
Analyst Upside
+158.8%
Supply-Chain & Ecosystem Map (Customers, Suppliers & Direct Competitors)
Bottleneck Score: 2/10
Drug Discovery Biotech
Drug Design
Top Competitors
218 stocks in Biotechnology| Company | Price | Market Cap | P/E | Score | Action |
|---|---|---|---|---|---|
|
OMER
Omeros Corporation
|
$13.70
-17.87%
|
$281.75M | 14.3 | 52 | Compare |
|
DBVT
DBV Technologies S.A.
|
$9.96
-3.02%
|
$275.54M | - | 29 | Compare |
|
VOR
Vor Biopharma Inc. Common Stock
|
$17.99
-5.17%
|
$269.08M | 0.1 | 51 | Compare |
|
VTYX
Ventyx Biosciences, Inc. Common Stock
|
$14.00
+0.14%
|
$256.71M | - | 51 | Compare |
|
SLN
Silence Therapeutics Plc American Depository Share
|
$19.79
-0.05%
|
$240.89M | - | 45 | Compare |
|
OABI
OmniAb, Inc. Common Stock
|
$5.01
+2.45%
|
$231.77M | - | 56 | Compare |
|
SGMT
Sagimet Biosciences Inc. Series A Common Stock
|
$9.73
-3.95%
|
$227.00M | - | 50 | Compare |
|
SLS
SELLAS Life Sciences Group, Inc. Common Stock
|
$19.68
+163.41%
|
$211.22M | - | 32 | Compare |
|
ACRS
Aclaris Therapeutics, Inc.
|
$3.39
-6.10%
|
$202.58M | - | 40 | Compare |
|
CBIO
Crescent Biopharma, Inc. Common Stock
|
$13.30
-1.48%
|
$199.71M | - | 42 | Compare |
More CAMP Analysis
Data updated: Nov 17, 2026 | Industry: Biotechnology (SIC 2834)
218 stocks in this industry